Found 61 matching trials
Endophenotype for Alcohol Misuse in Healthy Minority Populations PHASE4 The purpose of the study is to understand the relationship between what an ...
Show More Location
University of Pennsylvania Treatment Research Center
Learn More & Join Trial
A Study of LY2216684 in Healthy Participants PHASE1 This study will evaluate the pharmacodynamic and pharmacokinetic interactio...
Show More Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Learn More & Join Trial
Examine the Feasibility of a Standardized Field Test for Marijuana and Alcohol Impairment: Laboratory Evaluations EARLY_PHASE1 Alcohol and Cannabis (CNB) are two of the most widely used intoxicants. The...
Show More Location
Hartford Hospital
Learn More & Join Trial
Risk Factor Analysis for Charcot Foot in Patients With Diabetes Mellitus: The Interplay of Inflammatory Cytokines and Metabolic Factors N/A Diabetes mellitus (DM) is among the most common metabolic disorders globall...
Show More Location
Multiple Locations
Learn More & Join Trial
Rituximab + High-Dose Methylprednisolone Debulking Prior to Venetoclax for CLL & SLL Patients PHASE1 The purpose of the study is to investigate whether the combination of ritux...
Show More Location
UCSD Moores Cancer Center
Learn More & Join Trial
Donor Stem Cell Transplant With No or Low-Intensity Chemotherapy Using Sirolimus and Treated Immune Cells to Treat Blood and Lymph Cancers PHASE2 Background:
Patients with cancers of the blood and immune system often ben...
Show More Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Learn More & Join Trial
A Pilot Study Using Short-Term Cultured Anti-Tumor Autologous Lymphocytes EARLY_PHASE1 To determine the feasibility and safety of administering a regimen of TIL/I...
Show More Location
Yale New Haven Hospital
Learn More & Join Trial
CD123 Redirected Autologous T Cells for AML EARLY_PHASE1 Pilot open-label study to estimate the feasibility, safety and efficacy of ...
Show More Location
Abramson Cancer Center of the University of Pennsylvania
Learn More & Join Trial
A Dose Determination and Safety Study of X4P-001 (Mavorixafor) in Participants With Warts, Hypogammaglobulinemia, Infections, and Myelokathexis (WHIM) Syndrome PHASE2 This is a Phase 2 study with an initial 24-week Treatment Period and an Ext...
Show More Location
University of Washington Medical Center
Learn More & Join Trial
NAI for Sepsis With Persistent Lymphopenia PHASE2 This is a Phase 2, randomized, open-label study evaluating the safety and e...
Show More Location
Multiple Locations
Learn More & Join Trial